Exercise recovery: May minimize muscle soreness, improve recovery, and increase oxygen efficiency during workouts
Despite broad preclinical support, human data are limited to a small number of low-quality, small-sample-size studies, and no large-scale randomized controlled trials have been published to date [4]
The Future of Cognitive Enhancement As neuroscience advances, cognitive enhancement is shifting away from simple stimulation and toward strategies that support deeper biological foundations of brain health
The FDA has approved semaglutide to treat cases of obesity with underlying atherosclerotic cardiovascular disease or a history of heart attack
Interesting to see how this behaves as a commercial product
Higher doses in trials have delivered about a 12% average body weight reduction over 72 weeks, with side effects similar to other GLP-1 medications